OVID Competitors & Alternatives
Compare Ovid Therapeutics Inc with similar stocks in the same industry
Biotechnology
OVID
Main Stock$2.32
Tradestie Score
54
Market Cap
$97.42M
Revenue Growth
8.4%
Analyst Upside
+135.8%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$20.71
|
$463.20M | - | 56 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.79
|
$457.09M | - | 62 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$5.37
|
$454.29M | - | 57 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$21.22
|
$448.32M | - | 65 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$24.51
|
$422.50M | - | 56 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$65.13
|
$410.79M | - | 50 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$11.60
|
$407.71M | - | 58 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.74
|
$386.68M | - | 54 | Compare |
More OVID Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry